These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26254433)

  • 1. Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data.
    Mpindi JP; Swapnil P; Dmitrii B; Jani S; Saeed K; Wennerberg K; Aittokallio T; Östling P; Kallioniemi O
    Bioinformatics; 2015 Dec; 31(23):3815-21. PubMed ID: 26254433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust statistical methods for hit selection in RNA interference high-throughput screening experiments.
    Zhang XD; Yang XC; Chung N; Gates A; Stec E; Kunapuli P; Holder DJ; Ferrer M; Espeseth AS
    Pharmacogenomics; 2006 Apr; 7(3):299-309. PubMed ID: 16610941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian Multi-Plate High-Throughput Screening of Compounds.
    Shterev ID; Dunson DB; Chan C; Sempowski GD
    Sci Rep; 2018 Jun; 8(1):9551. PubMed ID: 29934615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control-Plate Regression (CPR) Normalization for High-Throughput Screens with Many Active Features.
    Murie C; Barette C; Lafanechère L; Nadon R
    J Biomol Screen; 2014 Jun; 19(5):661-71. PubMed ID: 24352083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of hit detection and confirmation in single and duplicate high-throughput screenings.
    Wu Z; Liu D; Sui Y
    J Biomol Screen; 2008 Feb; 13(2):159-67. PubMed ID: 18216390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data.
    Ryall KA; Shin J; Yoo M; Hinz TK; Kim J; Kang J; Heasley LE; Tan AC
    Bioinformatics; 2015 Dec; 31(23):3799-806. PubMed ID: 26206305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the prediction of statistical parameters in high-throughput screening using resampling techniques.
    Ilouga PE; Hesterkamp T
    J Biomol Screen; 2012 Jul; 17(6):705-12. PubMed ID: 22460175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using clustering techniques to improve hit selection in high-throughput screening.
    Gagarin A; Makarenkov V; Zentilli P
    J Biomol Screen; 2006 Dec; 11(8):903-14. PubMed ID: 17092911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. tcpl: the ToxCast pipeline for high-throughput screening data.
    Filer DL; Kothiya P; Setzer RW; Judson RS; Martin MT
    Bioinformatics; 2017 Feb; 33(4):618-620. PubMed ID: 27797781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF; Asatryan H; Li J; Zhou Y
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of high-throughput RNAi screening data in identifying genes mediating sensitivity to chemotherapeutic drugs: statistical approaches and perspectives.
    Ye F; Bauer JA; Pietenpol JA; Shyr Y
    BMC Genomics; 2012; 13 Suppl 8(Suppl 8):S3. PubMed ID: 23281588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the Relationship between Molecular Hit Rates in High-Throughput Screening and Molecular Descriptors.
    Hansson M; Pemberton J; Engkvist O; Feierberg I; Brive L; Jarvis P; Zander-Balderud L; Chen H
    J Biomol Screen; 2014 Jun; 19(5):727-37. PubMed ID: 23975880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid median filter background estimator for correcting distortions in microtiter plate data.
    Bushway PJ; Azimi B; Heynen-Genel S; Price JH; Mercola M
    Assay Drug Dev Technol; 2010 Apr; 8(2):238-50. PubMed ID: 20230301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breeze: an integrated quality control and data analysis application for high-throughput drug screening.
    Potdar S; Ianevski A; Mpindi JP; Bychkov D; Fiere C; Ianevski P; Yadav B; Wennerberg K; Aittokallio T; Kallioniemi O; Saarela J; Östling P
    Bioinformatics; 2020 Jun; 36(11):3602-3604. PubMed ID: 32119072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Titration-Based Screening for the Rapid Pilot Testing of High-Throughput Assays.
    Zhang JH; Kang ZB; Ardayfio O; Ho PI; Smith T; Wallace I; Bowes S; Hill WA; Auld DS
    J Biomol Screen; 2014 Jun; 19(5):651-60. PubMed ID: 24246376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.